Delayed Quote. Delayed  - 05/14 04:10:00 pm
40.02USD -0.20%

Pfizer Raises Full-Year Profit Guidance, Expects Higher Covid-19 Vaccine Sales

05/04/2021 | 07:21am

By Matt Grossman

Pfizer Inc. on Tuesday raised its full-year revenue and earnings guidance, citing a higher estimate of sales of its Covid-19 vaccine.

Pfizer now expects full-year revenue of $70.5 billion to $72.5 billion, compared with previous guidance for revenue of $59.4 billion to $61.4 billion.

The company forecast a full-year adjusted profit of $3.55 a share to $3.65 a share. It had previously said it expected an adjusted profit of $3.10 a share to $3.20 a share.

Pfizer expects its Covid-19 vaccine developed with BioNTech SE to generate revenue of about $26 billion in the year. It had previously guided for revenue of about $15 billion from the shot.

Write to Matt Grossman at

(END) Dow Jones Newswires

05-04-21 0721ET

Copier lien
All news about PFIZER, INC.
1d ago
1d ago
1d ago
1d ago
1d ago